2020 WEF Annual Meeting: Presenting the 2020 Antimicrobial Resistance Benchmark
What leaders say
I’ve been impressed by the Access to Medicine Index. It presents well-balanced stakeholder views on good practices for the pharmaceutical industry and it provides clear standards against which the performance of individual companies can be judged.
President, Realizing Rights, Former UN High Commissioner for Human Rights (1997-2002), Former President of Ireland (1990-1997)
The Access to Medicine Index is a very important project. What gets measured, gets done.
Dr. Margaret Chan
Former Director General, World Health Organisation
When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that.
Co-chair and Trustee, Bill & Melinda Gates Foundation
The Access to Medicine Foundation is featured in
View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.